|
JPMORGAN MULTI-ASSET TRUST PLC (the 'Company') |
|
|
Legal Entity Identifier: 549300C0UCY8X2QXW762 |
|
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 28 February 2019 |
|
|
JPMorgan Global High Yield Bond Fund |
13.2% |
|
Infrastructure Investments Fund |
11.3% |
|
JPMorgan Emerging Markets Debt Fund |
5.0% |
|
MSCI EMGMKT (New Style) Index Equity (Future) |
4.8% |
|
US ULTRA (New Style) Bond Commodity (Future) |
4.3% |
|
Pfizer |
3.1% |
|
Coca-Cola |
2.7% |
|
Merck |
2.5% |
|
Novartis |
2.2% |
|
Roche Holdings |
2.2% |
|
Total |
51.3% |
|
Name of contact and telephone number for queries: |
|
|
Paul Ainger 0044 207 742 6524 |
|
|
Name of authorised company official responsible for making this notification: |
|
|
Paul Winship 0044 207 742 9815 - Company Secretary |
|
|
Date: 13 March 2019 |
|
|
|
|